By / July 8, 2020

Deregulation of cannabis will improve all of Uruguay’s exporting procedures

The pro secretary of the Presidency of Uruguay, Rodrigo Ferrés, and the National Secretary of Drugs, Daniel Radío, received this Monday in Torre Ejecutiva a delegation of the Chamber of Companies of Medical Cannabis and agreed on the constitution of a commission to analyze modifications to the decree 46/2015 that regulates this activity. 

Ferrés (also president of the National Drug Board) said in a press conference that President Luis Lacalle Pou “made the decision to promote this incipient industry that can generate many resources, work and, because of its production quality, a country brand. 

If you want to know more about cannabis, how Uruguay is looking to deregulate cannabis in order to facilitate its exportation, and to find out the latest hemp news, download the mobile application.

The deregulation of cannabis will help improve all exporting operations

In this sense, he said that he will seek to “improve the legal framework” to “improve the operation” of the medical cannabis industry and that “it can develop its greatest potential,” especially in terms of exports.

According to Ferrés, the planned changes will not be aimed at the law regulating cannabis, but rather at the decrees that “cause delays” and “procedures that slow down the authorization to export.” 

“We want to work on deregulation. Of course, when it comes to questions related to medicine (it should be) in accordance with what the Executive Branch, through the Ministry of Public Health, determines on scientific and technical bases, and determinations that the companies will have to comply,” he added. 

“There are aspects to be adjusted with respect to different procedures, granting of authorizations and licenses, to facilitate the development of this industry, especially with regard to exports,” said Ferrés.

The Assistant Secretary of the Presidency reported that “all the licenses that are requested and comply with the requirements” in the area of medical cannabis will be granted. 

“The idea is to boost the hemp industry in general. That Uruguay can have one more industry, with more sources of work, more investment, and that it be a reason to stand out in the world, as is the case today with meat,” he said.

Uruguay is planning to recognize the hemp industry as the largest in the country

In a similar vein, the president of the Chamber of Medicinal Cannabis Companies, Marco Algorta, said after the meeting that Uruguay XXI recognizes the hemp industry as “the potentially largest industry in the country, which could be larger than cellulose and livestock. 

“It generates a lot of labor per dollar invested, twice as much as normal. Now 1,000 people work there, but it could quickly escalate,” he said. 

Algorta stressed that the authorities agree on “the potential” of the sector, as well as on the diagnosis that “today the industry is blocked and we have to update current regulations to make it viable.” 

“Currently, it is very difficult to come and invest with the current regulations. The regulation dates from February 2015, when there was no foreign trade in medical cannabis. It is a regulation that precedes practice,” he said, although he noted that the law “is perfect” and “should not be changed.”

Radio, who was formally presented as Secretary of Drugs, said that he shares the government’s guidelines on this issue in that “we must encourage and facilitate processes.” 


(Featured image by RENAN SAVIDAN via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in El Observador, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Comments are closed for this post.